Ampco-Pittsburgh Corporation (NYSE: AP) Announces Fourth Quarter and Full Year 2021 Results
Full-year backlog growth of 19% with Forged Engineered Products backlog up 319% Full-year sales growth…
Month: March 2022
E2open Introduces Strategic Advisory Board; Members to Address Supply Chain Resiliency and Solutions at CONNECT 2022
AUSTIN, Texas–(BUSINESS WIRE)–E2open Parent Holdings, Inc. (NYSE: ETWO), a leading network-based provider of a cloud-based,…
Cognito Appoints New VP to Financial Communications Practice
Taylor Fenske joins financial services agency as Vice President; Andrew Marshall relocates to New York…
Sensata Technologies Announces Strategic Collaboration with NIRA Dynamics to Develop Tire Tread Depth Monitor Solution
Sensata’s new tire Tread Depth Monitoring (TDM) solution, powered by NIRA Dynamics’ tread wear estimation…
Kingston Technology Tops List of Supplier Channel SSD Shipments in 2021
Continued Growth in Q4 Solidified #1 Ranking for the Year FOUNTAIN VALLEY, Calif.–(BUSINESS WIRE)–#KingstonIsWithYou–Kingston Digital,…
OXIO Raises $40 Million to Launch in the U.S. and Brazil; Introduces Telecom-as-a-Service to Turn Established Brands into Telecom Carriers
Backed by Web3 Investors, Including ParaFi Capital, Digital Currency Group and Multicoin Capital, OXIO Raises…
BioNTech to Report Full Year and Fourth Quarter 2021 Financial Results and Operational Update on March 30, 2022
MAINZ, GERMANY, March 16, 2022 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the…
Mountain Valley MD Holdings Appoints Dr. Elizabeth Norton to Advisory Role to Support Key Quicksome™ Vaccine and Cold Chain Projects
TORONTO, March 16, 2022 (GLOBE NEWSWIRE) — Mountain Valley MD Holdings Inc. (the “Company” or…
BioCorRx Announces IRB Approval to Begin Phase I Clinical Trial of BICX104, an Implantable Biodegradable Naltrexone Pellet for the Treatment of Opioid Use Disorder
ANAHEIM, CA, March 16, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — BioCorRx Inc. (OTCQB: BICX) (the “Company”),…
Yield10 Bioscience Chief Executive Officer Dr. Oliver Peoples to Present on Development of Camelina Crop for Use in Biofuels at ABLC 2022 Conference
-Establishing the Camelina crop as a replenishable reserve of feedstock oil for biofuels -Winter Camelina…
LIXTE Biotechnology Holdings, Inc. to Present at MedInvest Pharmaceutical and Biotechnology Investor Conference
PASADENA, CA, March 16, 2022 (GLOBE NEWSWIRE) — LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage…
Sana Biotechnology Reports Fourth Quarter and Full Year 2021 Financial Results and Business Updates
Plans to present data at multiple scientific conferences in 2022 Expects to file INDs for…
Radius Health Announces Leadership Appointments
BOSTON, March 16, 2022 (GLOBE NEWSWIRE) — Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq:…
RespireRx Pharmaceuticals Inc. Announces Discovery of a New GABAkine Neuromodulator that Protects Against Seizures and Lethality
Glen Rock, N.J., March 16, 2022 (GLOBE NEWSWIRE) — RespireRx Pharmaceuticals Inc. (OTCQ:RSPI) (“RespireRx” or…
BetterLife Obtains In Vivo PK Data for BETR-001 Confirming its Bioavailability in Brain
VANCOUVER, British Columbia, March 16, 2022 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the…
Werewolf Therapeutics Announces Publication of Data Demonstrating the Preclinical Efficacy of WTX-124 in Delivering IL-2 Selectively to the Tumor Microenvironment
CAMBRIDGE, Mass., March 16, 2022 (GLOBE NEWSWIRE) — Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”)…
Cytovia Therapeutics to Present Preclinical Data for iPSC-derived NK Cells and Flex-NK™ Engager Multispecific Antibodies at 2022 AACR Annual Meeting
AVENTURA, Fla. and NATICK, Mass., March 16, 2022 (GLOBE NEWSWIRE) — Cytovia Therapeutics, Inc., a biopharmaceutical…
Dialco Medical Announces Formation of Medical Advisory Board to Support the Continued Development of DIMI Device
TORONTO, March 16, 2022 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:…
Palisade Bio (Nasdaq: PALI) Announces Analysis Demonstrating LB1148 Reduced the Extent and Severity of Post-Surgical Intraabdominal Adhesions by 93%
Data from Pooled-Analysis of Enteral Protease Inhibitor LB1148 Demonstrated 72% Reduction in the Risk of…
SOTIO Announces Oral and Multiple Poster Presentations on Key Clinical Programs at the American Association of Cancer Research Annual Meeting (AACR) 2022
Oral presentation will focus on interim efficacy and safety data from the Phase 1/1b AURELIO-03…